Want to see JP:9989 full AI Analyst Report?
9989 Stock Chart & Stats
¥3723.00
¥64.00(1.67%)
At close: 4:00 PM EDT
¥3723.00
¥64.00(1.67%)
Day’s Range― - ―
52-Week Range¥3,526.00 - ¥4,663.00
Previous CloseN/A
Volume462.60K
Average Volume (3M)517.71K
Market Cap
¥436.24B
Enterprise Value¥431.73K
Total Cash (Recent Filing)¥61.35B
Total Debt (Recent Filing)¥47.97B
Price to Earnings (P/E)13.7
Beta0.20
Next Earnings
Nov 18, 2026EPS Estimate
69.81Next Dividend Ex-DateN/A
Dividend Yield3.53%
Share Statistics
EPS (TTM)268.97
Shares Outstanding119,331,184
10 Day Avg. Volume509,410
30 Day Avg. Volume517,713
Financial Highlights & Ratios
PEG Ratio7.02
Price to Book (P/B)1.60
Price to Sales (P/S)0.54
P/FCF Ratio35.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥4,315.00Price Target Upside15.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)284.26
Revenue Forecast (FY)¥894.20B
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthSustained revenue expansion indicates ongoing customer demand across pharmaceuticals, health and beauty products, and daily necessities. This broad assortment supports repeat visits and provides a durable base for continued store-network sales growth.
Conservative Balance SheetA large equity base and moderate leverage provide financial resilience and flexibility for store investment, working-capital needs, and business development. The balance sheet should help Sundrug absorb operating volatility better than a highly leveraged retailer.
Stable ProfitabilityConsistent operating and net margins show that Sundrug can convert its retail scale and recurring consumer demand into steady profits. Margin stability supports earnings visibility even when individual product categories or operating costs fluctuate.
Bears Say
Weak And Volatile Free Cash FlowWeak cash conversion can limit funds available for store expansion, shareholder distributions, and debt reduction despite reported earnings. If investment requirements or working-capital swings persist, long-term financial flexibility may remain constrained.
Rising DebtAlthough leverage remains moderate, the rising debt trend reduces balance-sheet flexibility and could increase financing needs over time. This becomes more material if profitability softens or free cash flow remains insufficient to fund investment internally.
Gross Margin PressureA lower gross margin suggests pressure from merchandise costs, pricing, or sales mix. If sustained, it could limit profit growth even with rising revenue, requiring continued efficiency gains and purchasing scale to protect the retailer’s earnings base.
Sundrug Co News
9989 FAQ
What was Sundrug Co Ltd’s price range in the past 12 months?
Sundrug Co Ltd lowest stock price was ¥3526.00 and its highest was ¥4663.00 in the past 12 months.
What is Sundrug Co Ltd’s market cap?
Sundrug Co Ltd’s market cap is ¥436.24B.
When is Sundrug Co Ltd’s upcoming earnings report date?
Sundrug Co Ltd’s upcoming earnings report date is Nov 18, 2026 which is in 68 days.
How were Sundrug Co Ltd’s earnings last quarter?
Sundrug Co Ltd released its earnings results on Aug 14, 2026. The company reported ¥68.53 earnings per share for the quarter, missing the consensus estimate of ¥69.475 by -¥0.945.
Is Sundrug Co Ltd overvalued?
According to Wall Street analysts Sundrug Co Ltd’s price is currently Undervalued.
Does Sundrug Co Ltd pay dividends?
Sundrug Co Ltd pays a Semiannually dividend of ¥66 which represents an annual dividend yield of 3.53%. See more information on Sundrug Co Ltd dividends here
What is Sundrug Co Ltd’s EPS estimate?
Sundrug Co Ltd’s EPS estimate is 69.81.
How many shares outstanding does Sundrug Co Ltd have?
Sundrug Co Ltd has 119,331,184 shares outstanding.
What happened to Sundrug Co Ltd’s price movement after its last earnings report?
Sundrug Co Ltd reported an EPS of ¥68.53 in its last earnings report, missing expectations of ¥69.475. Following the earnings report the stock price went up 0.483%.
Which hedge fund is a major shareholder of Sundrug Co Ltd?
Currently, no hedge funds are holding shares in JP:9989
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sundrug Co Ltd
Sundrug Co.,Ltd. engages in the drug store business in Japan. It operates through Drug Store Business and Discount Store Business segments. The Drug Store Business segment primarily sells pharmaceutical products, cosmetics, and daily necessities. The Discount Store Business segment offers food and household goods. The company was incorporated in 1957 and is headquartered in Fuchu, Japan.
9989 Stock 12 Month Forecast
Average Price Target
¥4,315.00
▲(15.90% Upside)
Technical Analysis
Sugi Holdings Co
―
TSURUHA Holdings
―
Create SD Holdings Co., Ltd.
―
COSMOS Pharmaceutical Corporation
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―








